Evidence map›Paper›PMID 35437872›Full record

ArticleClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology2023

Neutrophil phenotypes in bronchial airways differentiate single from dual responding allergic asthmatics.

Nicole van der Burg, Henning Stenberg, Sandra Ekstedt, Zuzana Diamant, Daisy Bornesund, Jaro Ankerst, Susanna Kumlien Georén, Lars-Olaf Cardell, Leif Bjermer, Jonas Erjefält and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Neutrophil phenotypes in bronchial airways differentiate single from dual responding allergic asthmatics.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2023
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 4 countries.

Nicole van der BurgDepartment of Clinical Sciences Lund, Respiratory Medicine and Allergology, Lund University, Lund, Sweden.ORCID 0000-0002-3369-6425
Henning StenbergDepartment of Clinical Sciences Lund, Respiratory Medicine and Allergology, Lund University, Lund, Sweden.
Sandra EkstedtDivision of ENT Diseases, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.
Zuzana DiamantDepartment of Clinical Sciences Lund, Respiratory Medicine and Allergology, Lund University, Lund, Sweden.ORCID 0000-0003-0133-0100
Daisy BornesundDepartment of Experimental Medical Science, Cell and Tissue biology, Lund University, Lund, Sweden.
Jaro AnkerstDepartment of Clinical Sciences Lund, Respiratory Medicine and Allergology, Lund University, Lund, Sweden.
Susanna Kumlien GeorénDivision of ENT Diseases, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.
Lars-Olaf CardellDivision of ENT Diseases, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0003-0538-9580
Leif BjermerDepartment of Clinical Sciences Lund, Respiratory Medicine and Allergology, Lund University, Lund, Sweden.
Jonas ErjefältDepartment of Experimental Medical Science, Cell and Tissue biology, Lund University, Lund, Sweden.ORCID 0000-0002-6716-3010
Ellen TufvessonDepartment of Clinical Sciences Lund, Respiratory Medicine and Allergology, Lund University, Lund, Sweden.ORCID 0000-0002-4941-332X
Lund University · SEKarolinska Institutet · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAllergic asthmatics with both an early (EAR) and a late allergic reaction (LAR) following allergen exposure are termed 'dual responders' (DR), while 'single responders' (SR) only have an EAR. Mechanisms that differentiate DR from SR are largely unknown, particularly regarding the role and phenotypes of neutrophils. Therefore, we aimed to study neutrophils in DR and SR asthmatics.

methodsThirty-four allergic asthmatics underwent an inhaled allergen challenge, samples were collected before and up to 24 h post-challenge. Cell differentials were counted from bronchial lavage, alveolar lavage and blood; and tissue neutrophils were quantified in immune-stained bronchial biopsies. Lavage neutrophil nuclei lobe segmentation was used to classify active (1-4 lobes) from suppressive neutrophils (≥5 lobes). Levels of transmigration markers: soluble (s)CD62L and interleukin-1Ra, and activity markers: neutrophil elastase (NE), DNA-histone complex and dsDNA were measured in lavage fluid and plasma.

resultsCompared with SR at baseline, DR had more neutrophils in their bronchial airways at baseline, both in the lavage (p = .0031) and biopsies (p = .026) and elevated bronchial neutrophils correlated with less antitransmigratory IL-1Ra levels (r = -0.64). DR airways had less suppressive neutrophils and more 3-lobed (active) neutrophils (p = .029) that correlated with more bronchial lavage histone (p = .020) and more plasma NE (p = .0016). Post-challenge, DR released neutrophil extracellular trap factors in the blood earlier and had less pro-transmigratory sCD62L during the late phase (p = .0076) than in SR.

conclusionDR have a more active airway neutrophil phenotype at baseline and a distinct neutrophil response to allergen challenge that may contribute to the development of an LAR. Therefore, neutrophil activity should be considered during targeted diagnosis and bio-therapeutic development for DR.

Indexed as

AsthmaHypersensitivityAllergensBronchial Provocation TestsHistonesHumansNeutrophilsPhenotypeAllergensHistonesallergic asthmaCD62LIL-1Rainhaled allergen challengelate allergic reactionNETosisneutrophils

Identifiers

PMID35437872
PMCPMC10083921
OpenAlexW4224260134

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.